Publications (51) CARLOS PRIETO SÁNCHEZ publications

2024

  1. Rvisdiff: An R package for interactive visualization of differential expression

    Frontiers in Bioinformatics, Vol. 4

2023

  1. In-depth blood immune profiling of Good syndrome patients

    Frontiers in Immunology, Vol. 14

  2. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

    Cells, Vol. 12, Núm. 15

2022

  1. Effects of copy number variations on brain structure and risk for psychiatric illness: Large-scale studies from the ENIGMA working groups on CNVs

    Human Brain Mapping, Vol. 43, Núm. 1, pp. 300-328

  2. SingleCAnalyzer: Interactive Analysis of Single Cell RNA-Seq Data on the Cloud

    Frontiers in Bioinformatics, Vol. 2

2021

  1. 1q21.1 distal copy number variants are associated with cerebral and cognitive alterations in humans

    Translational psychiatry, Vol. 11, Núm. 1, pp. 182

  2. Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis

    Frontiers in Pharmacology, Vol. 12

  3. Induction of antiviral and cell mediated immune responses significantly reduce viral load in an acute foot-and-mouth disease virus infection in cattle

    Genomics, Vol. 113, Núm. 6, pp. 4254-4266

  4. The Hydropathy Index of the HCDR3 Region of the B-Cell Receptor Identifies Two Subgroups of IGHV-Mutated Chronic Lymphocytic Leukemia Patients With Distinct Outcome

    Frontiers in Oncology, Vol. 11

  5. Whole-Exome Sequencing Reveals Recurrent but Heterogeneous Mutational Profiles in Sporadic WHO Grade 1 Meningiomas

    Frontiers in Oncology, Vol. 11

2020

  1. Association of Copy Number Variation of the 15q11.2 BP1-BP2 Region with Cortical and Subcortical Morphology and Cognition

    JAMA Psychiatry, Vol. 77, Núm. 4, pp. 420-430

  2. Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia

    Molecular Psychiatry, Vol. 25, Núm. 3, pp. 584-602

  3. Heterogeneous EGFR, CDK4, MDM4, and PDGFRA gene expression profiles in primary GBM: No association with patient survival

    Cancers, Vol. 12, Núm. 1

  4. RaNA-Seq: Interactive RNA-Seq analysis from FASTQ files to functional analysis

    Bioinformatics, Vol. 36, Núm. 6, pp. 1955-1956

2019

  1. Altered gene expression in antipsychotic-induced weight gain

    npj Schizophrenia, Vol. 5, Núm. 1

  2. Defects in memory B-cell and plasma cell subsets expressing different immunoglobulin-subclasses in patients with CVID and immunoglobulin subclass deficiencies

    Journal of Allergy and Clinical Immunology, Vol. 144, Núm. 3, pp. 809-824

  3. Frequency and prognostic impact of KIT and other genetic variants in indolent systemic mastocytosis

    Blood, Vol. 134, Núm. 5, pp. 456-468

  4. Sex differences in gene expression related to antipsychotic induced weight gain

    PLoS ONE, Vol. 14, Núm. 4

  5. Time dependent expression of the blood biomarkers EIF2D and TOX in patients with schizophrenia

    Brain, Behavior, and Immunity, Vol. 80, pp. 909-915

2018

  1. Blood gene expression profile predicts response to antipsychotics

    Frontiers in Molecular Neuroscience, Vol. 11